Perceptive Capital Solutions Corp (PCSC), sponsored by affiliates of Perceptive Advisors, a healthcare and life sciences investment firm, is currently in an active business combination process after filing a Form 425 communication with the SEC on July 9, 2026. Form 425 filings are reserved for written communications related to proposed mergers and signal that PCSC has announced a combination target and is progressing toward a transaction close. The vehicle is focused on the healthcare and life sciences sector, consistent with Perceptive Advisors' established investment mandate in biopharmaceutical and medical technology companies. For complete deal timelines, target company profiles, and full filing history on PCSC, sign up for access on SpacDesk.